About the Study : This randomized clinical trial found that digital PRO monitoring was associated with clinically meaningful reductions in fatigue and improved physical functioning. These findings support further evaluation of alert-based PRO monitoring in routine oncology care.
Visit JAMA+ AI for research, commentary, and multimedia content curated by Roy Perlis, MD, MSc.
Corresponding Author : Maria Margarete Karsten, Dr habil, Department of Gynecology with Breast Center, Charité–Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany ( maria-margarete.karsten@charite.de ).
10.1001/jamaoncol.2026.2661
To access the embargoed study: Visit our JAMA Network Media Center at this link https://media.jamanetwork.com/
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Editor's Note : Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
JAMA Oncology